Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Peritoneal Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Stomach Neoplasms 31 Ovarian Neoplasms 27 Peritoneal Neoplasms 24 Colorectal Neoplasms 13 Fallopian Tube Neoplasms 12 Carcinoma, Ovarian Epithelial 9 Appendiceal Neoplasms 7 Recurrence 3 Pseudomyxoma Peritonei 3 Neoplasm Metastasis 3 Carcinoma 3 Uterine Neoplasms 2 Sarcoma 2 Neoplasms 2 Mesothelioma, Malignant 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gastric Adenocarcinoma 2 Desmoplastic Small Round Cell Tumor 2 Colonic Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Stomach Diseases 1 Stage Ⅲ Gastric Cancer 1 Stage IV Gastric Cancer With Metastasis 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pleural Effusion 1 Peritoneal Metastases From Gastric Cancer 1 Peritoneal Metastases From Colorectal Cancer 1 Peritoneal Diseases 1

Interventions

Oxaliplatin 2 Paclitaxel 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1 Bupivacaine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡